HALOZYME THERAPEUTICS INC (HALO) Stock Income Statement
NASDAQ:HALO • US40637H1095
Current stock price
63.43 USD
+0.16 (+0.25%)
At close:
63.43 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.40B | 1.02B | 829.25M | 660.10M | 443.30M | |||
| Cost Of Goods | 228.77M | 159.42M | 192.36M | 139.30M | 81.40M | |||
| Gross Profit | 1.17B | 855.91M | 636.89M | 520.80M | 361.90M | |||
| Operating Expenses | 351.54M | 304.43M | 296.82M | 231.40M | 86.00M | |||
| Research and Development | 81.49M | 79.05M | 76.36M | 66.60M | 35.70M | |||
| Selling, General, and Administrative Expenses | 193.39M | 154.34M | 149.18M | 121.60M | 50.30M | |||
| Operating Income | 816.29M | 551.48M | 340.07M | 289.40M | 275.90M | |||
| Interest Income/Expense | 3.35M | 5.66M | -2.44M | -15.90M | -6.40M | |||
| Other Income/Expense | 0.00 | 0.00 | 13.20M | N/A | N/A | |||
| Non Recurring Items | -352.76M | 0.00 | -2.50M | -24.60M | -21.00M | |||
| Income Before Taxes | 466.88M | 557.13M | 348.33M | 248.90M | 248.50M | |||
| Income Tax | 149.99M | 113.04M | 66.73M | 46.80M | -154.20M | |||
| Net Income | 316.89M | 444.09M | 281.59M | 202.10M | 402.70M | |||
| EBITDA | 904.34M | 632.79M | 424.93M | 339.00M | 278.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.56 | 3.43 | 2.10 | 1.44 | 2.74 | |||
| Non GAAP EPS | 4.13 | 4.23 | 2.78 | 2.22 | 1.92 | |||
| Statistics | ||||||||
| Gross Profit Margin | 83.62% | 84.30% | 76.80% | 78.90% | 81.64% | |||
| Profit Margin | 22.69% | 43.74% | 33.96% | 30.62% | 90.84% | |||
| Operating Profit Margin | 58.45% | 54.32% | 41.01% | 43.84% | 62.24% | |||
All data in USD